Trials / Enrolling By Invitation
Enrolling By InvitationNCT07274579
An Artificial Intelligence Model for Aiding Claudin18.2 Expression Diagnosis in Gastric Adenocarcinoma
Development and Real-World Validation of an Intelligent Interpretation Model for Claudin18.2 Protein Expression in Digestive System Tumors
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Nanfang Hospital, Southern Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators plan to develop a deep learning-based automatic interpretation model for Claudin18.2(CLDN18.2) using the institution's and multiple other centers' extensive pathological resources of digestive system adenocarcinomas. This study will not only strictly follow the latest domestic expert consensus and standards, but also aims to address current pain points in manual interpretation. It seeks to provide technical support for standardizing, objectifying, and streamlining CLDN18.2 testing, thereby advancing the application of precision medicine in the diagnosis and treatment of digestive system diseases. The project has clear clinical necessity and broad application prospects.
Conditions
Timeline
- Start date
- 2025-10-01
- Primary completion
- 2028-07-01
- Completion
- 2028-08-01
- First posted
- 2025-12-10
- Last updated
- 2026-02-10
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT07274579. Inclusion in this directory is not an endorsement.